isoborneol has been researched along with Epilepsy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Ji, XM; Jiang, XH; Liu, JY; Qiu, XY; Sun, MJ; Tan, B; Wang, F; Wang, Y; Xu, CL | 1 |
| Bai, B; Chen, R; Gao, F; Li, A; Li, S; Mi, R; Xue, G | 1 |
| Ghumatkar, P; Jain, P; Patil, S; Sathaye, S; Tambe, R | 1 |
3 other study(ies) available for isoborneol and Epilepsy
| Article | Year |
|---|---|
(+)-Borneol enantiomer ameliorates epileptic seizure via decreasing the excitability of glutamatergic transmission.
Topics: Animals; Anticonvulsants; Camphanes; Disease Models, Animal; Epilepsy; Kindling, Neurologic; Mice; Seizures | 2023 |
(+)-Borneol exerts neuroprotective effects via suppressing the NF-κB pathway in the pilocarpine-induced epileptogenesis rat model.
Topics: Animals; Cyclooxygenase 2; Epilepsy; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; Pilocarpine; Rats; Tumor Necrosis Factor-alpha | 2023 |
Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice.
Topics: Animals; Anticonvulsants; Brain; Camphanes; Catalase; Convulsants; Disease Models, Animal; Epilepsy; Glial Fibrillary Acidic Protein; Glutathione; Kindling, Neurologic; Lipid Peroxidation; Male; Mice; Oxidative Stress; Pentylenetetrazole; Superoxide Dismutase | 2016 |